-
E-mail
boxun@boxun.com.cn
-
Phone
15921550609
-
Address
9th Floor, Shenhang Building, No. 198 Zhongshan North Road, Shanghai, China
Shanghai Boxun Medical Biological Instrument Co., Ltd
Boxun Biotechnology has been awarded the highest level "A" evaluation for information disclosure by the Beijing Stock Exchange
Date: 2025-11-05Read: 26
Recently, the Beijing Stock Exchange announced for the first time the evaluation of information disclosure of listed companies, and Boxun Biotechnology was awarded the highest level of "A" (excellent) evaluation. According to statistics, among the 262 listed companies on the Beijing Stock Exchange evaluated this time, only 48 were rated as Class A (excellent) companies, accounting for 18.3%. The A-class (excellent) evaluation of information disclosure obtained this time is a full recognition of the efforts made by regulatory agencies, investors, and market parties in the standardized operation, honest operation, and investor rights protection of Boxun Biotechnology. It fully reflects the high recognition of the company by regulatory agencies in information disclosure, standardized operation, corporate governance, and investor protection.
Information disclosure is a key way for listed companies to convey their core values and an important basis for investor decision-making. Its core includes the standardization and effectiveness of information disclosure, investor relations and public relations maintenance, and disclosure related to social responsibility performance; The information disclosure evaluation system constructed by the Beijing Stock Exchange also revolves around core aspects such as corporate governance, information disclosure quality, investor relations maintenance, and social responsibility fulfillment, forming a multidimensional comprehensive evaluation framework. Class A is an excellent level.
Since entering the capital market in 2023, the company has always strictly adhered to laws, regulations, and internal system norms, and upheld the principles of high standards and high-quality information disclosure. On the basis of fulfilling its legal disclosure obligations, the company actively responds to investors' concerns, continuously deepens the depth and breadth of voluntary information disclosure, increases the active disclosure of investors' attention to hot topics, and continuously improves the readability of announcements and the effectiveness of information transmission.
Looking ahead to the future, the company will always adhere to a long-term approach, guided by long-term healthy and sustainable development, continuously deepen corporate governance, improve standardized operations, effectively safeguard the legitimate rights and interests of investors, comprehensively strengthen information disclosure construction and quality control, actively assume social responsibility, steadily enhance core investment value, and contribute the solid strength of Boxun to the healthy and stable development of the capital market.